Elanco Animal Health said on Tuesday it would buy Bayer’s veterinary drugs unit in a cash and stock deal valued at $7.6 billion, creating the second largest animal health business and expanding Elanco’s reach in the pet e-commerce space.
Source:: Reuters – Business News